BeOne Medicines Ltd.

ONC Nasdaq SEC CIK 1651308
Follow BeOne Medicines Ltd. Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $1.9B +33.8% vs same quarter last year
Net income $384.7M +208.2% vs same quarter last year
EPS, diluted $0.25 +212.5% vs same quarter last year
Operating cash flow $508.7M +26.4% vs same quarter last year
Revenue by quarter
$1.1B
$1.1B
$1.3B
$1.4B
$1.5B
$1.5B
$1.7B
$1.9B
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income13 fiscal years
  • Revenue
  • Net income
−$4B−$2B$0$2B$4B$6BFY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$5.3B$286.9M
FY24$3.8B−$644.8M
FY23$2.5B−$881.7M
FY22$1.4B−$2B
FY21$1.2B−$1.5B
FY20$308.9M−$1.6B
FY19$428.2M−$948.6M
FY18$198.2M−$673.8M
FY17$238.4M−$93.1M
FY16$1.1M−$119.2M
FY15$8.8M−$57.1M
FY14$13M−$18.3M
FY13--
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−15000%−10000%−5000%0%5000%FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2587.5%8.4%5.4%
FY2484.4%−14.9%−16.9%
FY2384.5%−49.1%−35.9%
FY2279.8%−126.4%−141.5%
FY2186%−122.3%−123.9%
FY2077.1%−536.7%−526.1%
FY1983.4%−224.2%−221.5%
FY1885.5%−356.1%−339.9%
FY1797.9%−41.3%−39.1%
FY16100%−10940.2%−11141.8%
FY15-−643.7%−647.7%
FY14-−120.9%−140.2%
FY13---
Free cash flowOperating cash flow minus capital expenditure
−$2B−$1B$0$1BFY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25$941.7M
FY24−$633.3M
FY23−$1.7B
FY22−$1.8B
FY21−$1.6B
FY20−$1.4B
FY19−$839.9M
FY18−$618M
FY17−$33.6M
FY16−$113M
FY15−$45.2M
FY14−$9.3M
FY13-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • BeOne Medicines Ltd.
  • Healthcare median
−15000%−10000%−5000%0%5000%FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearBeOne Medicines Ltd.Healthcare median
FY255.4%−30.6%
FY24−16.9%−47%
FY23−35.9%−58%
FY22−141.5%−80.4%
FY21−123.9%−71.9%
FY20−526.1%−62.2%
FY19−221.5%−46.3%
FY18−339.9%−49.6%
FY17−39.1%−45.9%
FY16−11141.8%−36%
FY15−647.7%−38.4%
FY14−140.2%−35.5%
FY13-−37.1%